Cellectis (CLLS) PT Lowered to $8 at Baird

September 14, 2026 8:58 AM

Baird analyst Madhu Kumar lowered the price target on Cellectis (NASDAQ: CLLS) to $8.00 (from $10.00) while maintaining a Outperform rating.

No results found